Short communicationA simultaneous plasma level and EEG assessment of an oral hypnotic (ETHINAMATE (cas 126-52-3))
-
Add time:09/10/2019 Source:sciencedirect.com
A double blind placebo controlled study of the hypnotic ethinamate was carried out in normals using simultaneous EEG and plasma level assessement. EEG ‘sleep scores’ were 3 times higher for drug than placebo and the peak plasma level preceded the maximum EEG score by 15 min.
We also recommend Trading Suppliers and Manufacturers of ETHINAMATE (cas 126-52-3). Pls Click Website Link as below: cas 126-52-3 suppliers
Prev:Research ArticlesGLC Determination of ETHINAMATE (cas 126-52-3) and Its Hydroxy Derivative in Biological Fluids
Next:ETHINAMATE (cas 126-52-3) (valmid) in dentistry) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- ArticlesThe Pharmacology and Toxicology of 'Valmid' (ETHINAMATE (cas 126-52-3), Lilly)09/27/2019
- Scientific EditionAn Investigation of the Possible Potentiation of ETHINAMATE (cas 126-52-3) Activity by Chlorpromazine*09/26/2019
- NoteIdentification of ETHINAMATE (cas 126-52-3), Ethchlorvynol, and Methylparafynol09/25/2019
- ETHINAMATE (cas 126-52-3) (valmid) in dentistry09/24/2019
- Research ArticlesGLC Determination of ETHINAMATE (cas 126-52-3) and Its Hydroxy Derivative in Biological Fluids09/09/2019
